Key result
Roux-en-Y gastric bypass improved mGFR/BSA and vascular function at 1 year in nondiabetic subjects with severe obesity (P<0.001), though absolute mGFR did not change.
Why the study?
Bariatric surgery may ameliorate renal function via vascular mechanisms, but its ability to improve mGFR and the clinical, renal, and systemic vascular predictors of improvement needed evaluation.
Does Roux-en-Y gastric bypass improve measured glomerular filtration rate and vascular function in nondiabetic individuals with severe obesity?
Cohort (n=25)
Does Roux-en-Y gastric bypass improve measured glomerular filtration rate and vascular function in nondiabetic individuals with severe obesity?
p-value: p=<0.001
In nondiabetic patients with severe obesity, bariatric surgery improves body surface area-adjusted mGFR and systemic vascular function, with lower baseline renal resistive index predicting greater renal improvement.
May support bariatric surgery benefits in nondiabetic severe obesity; hypothesis-generating and leaves randomized confirmation open.
OBJECTIVE: Bariatric surgery may ameliorate renal function through vascular mechanisms. This study tested surgery's ability to improve measured glomerular filtration rate (mGFR) and identified clinical, renal, and systemic vascular predictors of such improvement. METHODS: Twenty-five nondiabetic subjects with severe obesity were studied before and 1 year after Roux-en-Y gastric bypass, evaluating mGFR and renal plasma flow, basal renal resistive index (RI) and dynamic renal RI, renal visceral fat, and systemic vascular parameters, including flow-mediated dilation, aortic pulse wave velocity, and carotid intima media thickness and stiffness. RESULTS: , P < 0.001), whereas the absolute mGFR did not change. Renal plasma flow did not vary. RI decreased; flow-mediated dilation, pulse wave velocity, carotid intima media thickness, and carotid stiffness improved. mGFR changes after surgery (ΔmGFR/BSA) were associated with younger age and lower fasting glucose. Among vascular variables, an improved ΔmGFR/BSA was associated with smaller brachial artery diameter, lower intima media thickness, and lower RI; this latter association remained after adjusting for covariates. No measure of adiposity was associated with ΔmGFR. CONCLUSIONS: In subjects with obesity and normal renal function, bariatric surgery improves mGFR/BSA (although absolute mGFR is unchanged) and renal and systemic vascular function. Lower renal intravascular resistance can predict these improvements, maximizing them in relatively young individuals.
No takes yet. Share an insight, caveat, or question.
Solini et al. (2018) conducted a cohort in Severe obesity without diabetes (n=25). Roux-en-Y gastric bypass vs. Baseline (pre-surgery) was evaluated on measured glomerular filtration rate (mGFR) (p=<0.001). Roux-en-Y gastric bypass improved mGFR/BSA and vascular function at 1 year in nondiabetic subjects with severe obesity (P<0.001), though absolute mGFR did not change.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: